Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rieckmann

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
The New Biologist|February 1, 1991
Selective autoregulation of endothelins in primary astrocyte cultures: endothelin receptor-mediated potentiation of endothelin-1 secretionH Ehrenreich, R W Anderson, Y Ogino, et al.
Journal of Neurology|November 27, 2025
Is therapy-free remission a realistic goal with cladribine tablets in multiple sclerosis? New insights into the mechanism of action and clinical implications of immune reconstitution with cladribine tablets in MS therapyC Kleinschnitz, T Skripuletz, S Pfeuffer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2000
A quality network model for the daily care of multiple sclerosisL D Blumhardt, B J Vermeij, M Amato, et al.
Neurology|March 3, 2010
Rapid-onset central motor plasticity in multiple sclerosisD Zeller, K aufm Kampe, A Biller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1993
Potent stimulation of monocytic endothelin-1 production by HIV-1 glycoprotein 120H Ehrenreich, P Rieckmann, F Sinowatz, et al.
The Journal of Experimental Medicine|December 1, 1990
Endothelins, peptides with potent vasoactive properties, are produced by human macrophagesH Ehrenreich, R W Anderson, C H Fox, et al.
Neurology|July 23, 2008
Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trialF Fazekas, F D Lublin, D Li, et al.
Neurology|February 28, 2007
Safety and feasibility of long-term temozolomide treatment in patients with high-grade gliomaP Hau, D Koch, T Hundsberger, et al.
Journal of Neuroimmunology|February 12, 2015
MS susceptibility is not affected by single nucleotide polymorphisms in the MMP9 geneS Nischwitz, C Wolf, T F M Andlauer, et al.
Acta Neurologica Scandinavica|May 8, 2008
Cognitive fMRI and soluble telencephalin assessment in patients with localization-related epilepsyJ F A Jansen, M C G Vlooswijk, M H de Baets, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
The New Biologist|February 1, 1991
Selective autoregulation of endothelins in primary astrocyte cultures: endothelin receptor-mediated potentiation of endothelin-1 secretionH Ehrenreich, R W Anderson, Y Ogino, et al.
Journal of Neurology|November 27, 2025
Is therapy-free remission a realistic goal with cladribine tablets in multiple sclerosis? New insights into the mechanism of action and clinical implications of immune reconstitution with cladribine tablets in MS therapyC Kleinschnitz, T Skripuletz, S Pfeuffer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2000
A quality network model for the daily care of multiple sclerosisL D Blumhardt, B J Vermeij, M Amato, et al.
Neurology|March 3, 2010
Rapid-onset central motor plasticity in multiple sclerosisD Zeller, K aufm Kampe, A Biller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1993
Potent stimulation of monocytic endothelin-1 production by HIV-1 glycoprotein 120H Ehrenreich, P Rieckmann, F Sinowatz, et al.
The Journal of Experimental Medicine|December 1, 1990
Endothelins, peptides with potent vasoactive properties, are produced by human macrophagesH Ehrenreich, R W Anderson, C H Fox, et al.
Neurology|July 23, 2008
Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trialF Fazekas, F D Lublin, D Li, et al.
Neurology|February 28, 2007
Safety and feasibility of long-term temozolomide treatment in patients with high-grade gliomaP Hau, D Koch, T Hundsberger, et al.
Journal of Neuroimmunology|February 12, 2015
MS susceptibility is not affected by single nucleotide polymorphisms in the MMP9 geneS Nischwitz, C Wolf, T F M Andlauer, et al.
Acta Neurologica Scandinavica|May 8, 2008
Cognitive fMRI and soluble telencephalin assessment in patients with localization-related epilepsyJ F A Jansen, M C G Vlooswijk, M H de Baets, et al.
Pageof 15